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Concurrent presence of buccal mucosal and 
ophthalmologic lesions in Behcet’s syndrome 
 
Abstract 
Background: Behcet’s syndrome is a disease with different aspects in its clinical 
manifestations. The purpose of this study was to evaluate the simultaneous presence of 
oral mucosal and ophthalmologic lesions in patients with Behcet’s syndrome. 
Methods: From April 2012 to December 2014, 50 cases of Behcet’s syndrome who 
referred to the Departments of Ophtalmology, Oral Diseases and Infectious Diseases of 
Babol University Medical Sciences were entered into the study. The diagnosis of the 
disease was performed using the Iranian criteria for the diagnosis of Behcet’s syndrome.  
The demographic findings as well as clinical manifestations were recorded. 
Results:  Thirt-six (72%) were males and 14 (28%) were females. The mean age of the 
patients was 35.6±9 years. Oral aphthous (94%), ocular lesion (76%) and genital ulcers 
(70%) were the most clinical findings. The clinical onset of the disease in 43 (86%) was 
oral lesions and in 5 (10%) was ocular lesions. Among the forty-eight cases with oral 
lesions, 77% had ocular lesions concurrently. HLA-B5 was positive in 35 (70%) cases. 
Ocular lesion was seen in 33 of 35 (91.4%) cases versus 6 of 15 (40%) with HLA-B5 
positive and negative cases, respectively (p<0.05). Oral lesion was seen in 94.3% cases 
with positive HLA-B5 and in 100% cases with negative HLA-B5 (p>0.05). 
Conclusions: The results show that concurrent ophthalmic and oral lesions in Behcet’s 
syndrome are relatively high. HLA-B5 positive cases are associated with more 
ophthalmologic lesions.  
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Behcet’s disease is a recurrent inflammatory disorder involving various organs of the 
body with unknown etiology and is characterized with triad of oral aphtose, genital ulcers 
and ocular involvement (1). In 1990, new diagnostic criteria including recurrence  of oral 
lesions three times a year with two of the following findings were used for the diagnosis of 
the disease and these include: (uveitis or retinal vasculitis), recurrent genital ulcers, 
dermatologic findings like erythema nodosum, pseudofolliculitis and papulopustular 
lesions and positive pathergy test. The disease usually begins in the third decade of life and 
includes combinations of mucocutaneous, ocular, renal, cadiological, intestinal, pulmonary 
and neurological involvement (2). Other organs may be involved during the course of the 
disease as well. In Iran, the prevalence of the disease is 68 cases/100000 populations (3). 
Oral aphthous ulcer is painful with duration of 1-2 weeks. Ocular lesion is also associated 
with blindness and is the catastrophic finding during the course of the disease (4). The 
clinical manifestation of the disease is protean, so the purpose of this study was to evaluate 
the simultaneous presence of oral and ophthalmologic lesions in patients with Behcet’s 
syndrome in Babol, North of Iran. 
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Methods  
From April 2012 to December 2014, 50 cases of Behcet’s 
syndrome who referred to the Departments of Ophtalmology, 
Oral Diseases and Infectious Diseases were entered into the 
study. The diagnosis of the disease was performed using 
Iranian criteria for the diagnosis of Behcet’s syndrome 
(recurrent genital ulcers, ocular lesion including uveitis or 
retinal vasculitis, dermatological lesions including erythema 
nodosum, pseudofolliculitis and papular or pustular lesions 
and positive pathergy test). The presence of two of the above 
criteria was sufficed for the diagnosis of the disease.  
Demographic findings like age, sex as well as clinical 
manifestations in all cases were recorded. HLA-B5 also was 
assessed in all cases. Data were collected and analyzed. The 
difference for the development of ocular lesion with and 
without positive HLA-B5 cases was determined using X
2 
test. 
 
 
Results 
The mean age of these 50 patients (36 males, 14 females) 
was 35.6±9 years (ranged 13-55 years). The clinical 
manifestations of these patients are shown in table 1. 
Table 1. The clinical manifestations of Behcet’s syndrome 
in 50 cases 
Clinical manifestation No (%) 
Oral aphtous ulcer 48 (96) 
Ocular lesion 38 (76) 
Genital ulcer 35 (70) 
Skin lesion 30 (60) 
Cardiac involvement 5 (10) 
Pulmonary involvement 9 (18) 
Articular involvement 28 (56) 
 
 Renal, gastrointestinal and neurological involvement 
were seen in 6 (12%), 9 (18%) and 5 (10%) cases, 
respectively. The number of oral lesions were from 1 to 12 
lesions. Among the patients with oral aphthous ulcers, 41 
(82%) had painful lesion. The oral lesion was the initial 
clinical manifestation in 43 (86%) of cases. Ocular lesion 
was the initial manifestation in 5 (10%) of cases. Genital 
lesion was the initial clinical manifestation in 2 (4%) cases. 
HLA-B5 was positive in 35 (70%) cases. Ocular lesion was 
seen in 33 of 35 cases (91.4%) versus 6 of 15 (40%) with 
HLA-B5 negative (p<0.05). Oral lesion was seen in 94.3% 
cases with positive HLA-B5 and in 100% cases with 
negative HLA (p>0.05). 
Discussion 
In this study, we assessed 50 consecutive patients with 
Behcet’s syndrome who were admitted to our centers. The 
sex distribution in our series was similar with the findings of 
other researchers (2, 5, 6). The mean age of our cases was 
higher than 26 cases reported by Omidian et al. and 
previously reported by Mikaniki et al. in 100 cases (3, 7). In 
the current study, the initial clinical manifestation was oral 
aphthous (86%) followed with ocular lesion (10%) and 
genital ulcer (4%) and was similar with the findings of other 
researchers (8, 9).  
The mean age at the onset of the disease was consistent 
with the findings of other researchers (2, 3, 6,10, 11). The 
number of oral lesions and its recurrence in our study was 
similar with the finding of Sanatkhany et al. and others (8, 9, 
11, 12). Ocular lesions were found in 76% of our cases like 
the results of several reported studies (3, 13-16). But other 
studies reported ocular lesions in 30%-50% of their cases (7, 
10, 17). Regarding genital ulcers, we found them in 70% of 
our series but other studies reported genital ulcers in 30%-
84% of their cases (7, 9, 10, 18-21). The differences may be 
due to ethnicity, or other genetic factors. Regarding family 
history of the disease, we found it in 11(22%) of our cases 
but Shaker et al. and Al-Araji et al. reported 6.7% and 9.7% 
of their cases, respectively (22, 23).  
In this study, skin lesions were found in 60% of our 
cases. Our results were similar with the fundings obtained by 
other researchers (22, 24-26). An interesting finding in our 
study was more on the ocular involvement of those with 
HLA-B+ cases and a finding that was not reported 
previously. Further studies are required to confirm our 
results. In summary, the results show that a concurrent 
ophthalmic and oral lesion in Behcet’s syndrome is relatively 
high. HLA-B5 positive cases are associated with more 
ophthalmologic lesions. 
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